Article
Clone-level multi-modal prediction of tumour drug response
2026-05-11
Abstract excerpt
Tumour heterogeneity presents a major challenge for precision oncology, as genetically and phenotypically distinct tumour clones may respond differently to therapy. To address this, we introduce scClone2DR, a probabilistic multi-modal framework that predicts drug responses at the level of individual tumour clones by integrating single-cell DNA and RNA sequencing with ex-vivo drug-screening data. In simulations, sc...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 5d246fbb-d8a8-52fd-973a-6435fd678759
- DOI
- 10.64898/2026.05.06.723206
